Systemic Steroids for Peripheral Nerve Blocks

PHASE4CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Osteoarthritis, Hip
Interventions
DRUG

Dexamethasone

A lumbar plexus nerve block will be performed for patients undergoing hip arthroplasty. A total of 25cc's of 0.25% bupivacaine with 1:400,000 epinephrine will be administered for postoperative analgesia. Surgical anesthesia will be provided either by an intrathecal spinal block or general anesthesia. Successful blockade will be assumed if the patient has a decrease or loss of pinprick sensation in the femoral nerve distribution, which innervates the anterior thigh. If no evidence of blockade is present, testing will occur again at 30 minutes post block. Testing will be performed with a 25 gauge Whitacre needle and once present the area of testing will be marked with a surgical marking pen so that repeat sensory testing can be undertaken at that same site over the course of the study. The subjects will then receive dexamethasone (4 or 8 mg) or placebo (saline) based on arm placement.

DRUG

Bupivacaine

Bupivacaine will be used in lumbar plexus nerve block mixture.

DRUG

Epinephrine

Epinephrine will be used in lumbar plexus nerve block mixture.

PROCEDURE

Lumbar Plexus Nerve Block

This is the procedure that will be performed.

DRUG

Saline

Patients randomized to the placebo group will receive normal saline intravenously.

Trial Locations (1)

27157

Wake Forest University Baptist Medical Center, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT02464176 - Systemic Steroids for Peripheral Nerve Blocks | Biotech Hunter | Biotech Hunter